MRS and DTI of White Matter in Alzheimer's Disease

Alzheimer's Disease Clinical Trial

Official title:

MR Spectroscopy and Diffusion Tensor Imaging of White Matter in Alzheimer's Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00172900
• Other study ID #: 9461700320
• Status: Recruiting
• Phase: N/A
• First received: September 12, 2005
• Last updated: December 20, 2005
• Start date: June 2005

Study information

• Verified date: June 2005
• Source: National Taiwan University Hospital
• Contact: Ya-Fang Chen, MD
• Phone: 886-2-23123456
• Email: avon[@]ntumc.org
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

The white matter change of the Alzheimer's disease could be studied by diffusion tensor image and MR spectroscopy to see the microstructral and biochemical change.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 55 Years to 95 Years

Eligibility

Inclusion Criteria:

• probable Alzheimer's disease or subcortica type vascular dementia

Exclusion Criteria:

• large vessel infarct, major trauma

Study Design

Observational Model: Defined Population, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease
• Dementia, Vascular
• Vascular Dementia

Locations

Country	Name	City	State
Taiwan	Department of Medical Imaging, National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan,